BackFusion Pharmaceuticals Overview

Fusion Pharmaceuticals Net Income

Profitability analysis for FUSN.

Quarterly Net Income

-$33.67M
38.61% YoY

As of Mar 2024

Annual Net Income (TTM)

-$104.28M
13.35% YoY

Trailing 12 months ending Mar 2024

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...